Interferon alpha/beta signaling
基因
试剂
文献样例
产品评述样例
2 5 oligoadenylate synthetase like
2'-5'-oligoadenylate synthetase like
Egr-1
early growth response 1
总数:28
Monocyte 15-lipoxygenase gene expression requires ERK1/2 MAPK activity. 2010 至该文献
为了研究IL-13诱导的单核细胞15-脂氧合酶基因的表达与ERK1/2相关,采用了Santa Cruz Biotechnology的兔抗人Egr-1抗体进行了免疫印迹试验。 更多
GBP2
guanylate binding protein 2
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
HLA E (HLA E)
major histocompatibility complex, class I, E
总数:12
ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C. 2012 至该文献
为了研究ESCRT-III调控Aurora B介导的细胞脱落，采用了Serotec的FITC标记的抗MHC-I抗体进行流式细胞分选实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-F (HLA-F)
major histocompatibility complex, class I, F
总数:1
Progressive myopathy and defects in the maintenance of myotendinous junctions in mice that lack talin 1 in skeletal muscle. 2008 至该文献
为了研究talin 1在骨骼肌发育和功能中的作用，采用了Sigma的鼠抗MHCf单抗，进行免疫组化实验
IFI27
interferon alpha inducible protein 27
IFI35
interferon induced protein 35
IFI6
interferon alpha inducible protein 6
IFIT1
interferon induced protein with tetratricopeptide repeats 1
IFIT2
interferon induced protein with tetratricopeptide repeats 2
IFIT3
interferon induced protein with tetratricopeptide repeats 3
总数:1
Mycobacterial disease and impaired IFN-? immunity in humans with inherited ISG15 deficiency. 2012 至该文献
为了研究人中缺失ISG15损害IFN-gamma免疫并导致分支杆菌易感，采用了BD Biosciences的抗IFIT3抗体进行蛋白印迹实验。
IFITM1
interferon induced transmembrane protein 1
总数:1
Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer. 2010 至该文献
为研究MUC1-C和STAT1通路在人类不良预后乳癌中的相互作用，采用了Proteintech Group公司的抗IFITM1抗体进行免疫印迹试验。
IFITM2
interferon induced transmembrane protein 2
IFITM3
interferon induced transmembrane protein 3
IFNA1
interferon alpha 1
总数:11
The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide.. 2010 至该文献
为了研究伊波拉病毒VP35蛋白在调节病毒和脂多糖诱导的树突细胞成熟中的作用，采用了PBL Laboratories公司的抗IFNalpha抗体产品，进行了流式细胞分析实验。 更多
IFNA10
interferon alpha 10
IFNA14
interferon alpha 14
IFNA16
interferon alpha 16
IFNA17
interferon alpha 17
IFNA21
interferon alpha 21
IFNA4
interferon alpha 4
IFNA5
interferon alpha 5
IFNA6
interferon alpha 6
IFNA7
interferon alpha 7
IFNA8
interferon alpha 8
IFNAR1
interferon alpha and beta receptor subunit 1
总数:4
A phosphorylation-acetylation switch regulates STAT1 signaling. 2009 至该文献
为了研究磷酸化-乙酰化开关在调控STAT1信号通路中的作用，采用了Santa Cruz Biotechnology公司的IFNAR1抗体产品，进行了免疫印迹实验。 更多
IFNAR2
interferon alpha and beta receptor subunit 2
总数:4
A phosphorylation-acetylation switch regulates STAT1 signaling. 2009 至该文献
为了研究磷酸化-乙酰化开关在调控STAT1信号通路中的作用，采用了Santa Cruz Biotechnology公司的IFNAR2抗体产品，进行了免疫印迹实验。 更多
IFNB1
interferon beta 1
总数:9
Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria. 2009 至该文献
IP6K2
inositol hexakisphosphate kinase 2
IRF-1 (IRF-1)
interferon regulatory factor 1
总数:14
Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes. 2008 至该文献
为研究干扰素调控因子4(IRF-4)在EBV病毒感染人类B淋巴细胞中的作用，采用了Santa Cruz Biotechnology公司的抗IRF-1抗体进行蛋白质印迹试验。 更多
IRF-2 (IRF-2)
interferon regulatory factor 2
总数:7
Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes. 2008 至该文献
为研究干扰素调控因子4(IRF-4)在EBV病毒感染人类B淋巴细胞中的作用，采用了Santa Cruz Biotechnology公司的抗IRF-2抗体进行蛋白质印迹试验。 更多
IRF-3 (IRF-3)
interferon regulatory factor 3
总数:22
DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. 2012 至该文献
为了研究IRF-3依赖的先天性免疫反应，采用了Life Technologies 的抗IRF-3抗体进行了蛋白免疫印迹实验。 更多
IRF4
interferon regulatory factor 4
总数:6
Frequent expression of multiple myeloma 1/interferon regulatory factor 4 in Burkitt lymphoma. 2009 至该文献
为从222例症状明显的伯基特淋巴瘤患者中分析其MUM1, bcl-6 和CD138的表达模式与EBV的相关性，将Dako提供的抗MUM-1/IRF4抗体（克隆：MUM1P）用于免疫组织化学实验中。 更多
IRF5
interferon regulatory factor 5
总数:1
Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression. 2010 至该文献
为了说明IRF5同HATs和HDACs一起调控促炎细胞因子的转录水平表达，使用了Abcam公司的山羊抗IRF5多克隆抗体进行免疫共沉淀实验。
IRF6
interferon regulatory factor 6
总数:3
Human ?-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. 2012 至该文献
为了研究粘膜初级免疫受HD6自组装促进，采用了Difco的抗LPS抗体进行免疫细胞化学实验。 更多
IRF7
interferon regulatory factor 7
总数:4
Activation of anti-hepatitis C virus responses via Toll-like receptor 7. 2006 至该文献
为了研究Toll样受体7抵抗丙型肝炎病毒的机制，使用Santa Cruz公司抗IRF-7抗体进行western blot实验。 更多
IRF8
interferon regulatory factor 8
总数:4
IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways. 2006 至该文献
IRF9
interferon regulatory factor 9
总数:1
Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA. 2008 至该文献
为了说明SeV C蛋白可以抑制双链RNA的产生来限制PKR的激活，使用了Santa Cruz Biotechnology公司的抗IRF9抗体来进行蛋白印迹实验。
ISG15
ISG15 ubiquitin like modifier
总数:7
Mycobacterial disease and impaired IFN-? immunity in humans with inherited ISG15 deficiency. 2012 至该文献
为了研究人中缺失ISG15损害IFN-gamma免疫并导致分支杆菌易感，采用了Santa Cruz Biotechnology的抗ISG15抗体进行流式细胞筛选和免疫细胞化学实验。 更多
ISG20
interferon stimulated exonuclease gene 20
Jak1
Janus kinase 1
总数:22
Identification of human thioredoxin as a novel IFN-gamma-induced factor: mechanism of induction and its role in cytokine production. 2008 至该文献
为了研究thioredoxin是受IFN-gamma诱导的因子并在细胞因子产生过程中起作用，采用Santa Cruz的抗Jak1和抗磷酸化Jak1抗体进行蛋白印迹实验。 更多
MX2
MX dynamin like GTPase 2
MxA
MX dynamin like GTPase 1
OAS1
2'-5'-oligoadenylate synthetase 1
总数:2
A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L. 2007 至该文献
为了研究脊髓灰质炎病毒3C蛋白酶开放阅读框的一个RNA结构的作用，采用Abgent公司的抗OAS1多克隆抗体进行免疫印迹实验。 更多
OAS2
2'-5'-oligoadenylate synthetase 2
OAS3
2'-5'-oligoadenylate synthetase 3
PSMB8
proteasome 20S subunit beta 8
总数:3
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population. 2010 至该文献
为了研究免疫蛋白酶体在多发性硬化发病机制的作用，采用Affinity-Biomol International抗LMP7抗体进行免疫组织化学试验。 更多
RNASEL
ribonuclease L
SHP-1 (SHP-1)
protein tyrosine phosphatase non-receptor type 6
总数:16
The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo. 2009 至该文献
为了说明Lyn能抑制破骨细胞的形成，使用了Santa Cruz Biotechnology公司的SHP-1多克隆抗体进行免疫印迹实验。 更多
SHP-2 (SHP-2)
protein tyrosine phosphatase non-receptor type 11
总数:34
Autoamplification of Notch signaling in macrophages by TLR-induced and RBP-J-dependent induction of Jagged1. 2010 至该文献
为了研究在巨噬细胞中TLR和RBP-J对Notch信号自发放大的调节作用，采用Santa Cruz Biotechnology公司多克隆抗Shp2抗体进行了免疫印迹实验。 更多
SOCS3
suppressor of cytokine signaling 3
总数:10
Unique early gene expression patterns in human adult-to-adult living donor liver grafts compared to deceased donor grafts. 2009 至该文献
为了研究已故捐献者DD)和活人捐献者(LD)肝脏移植在分子水平上的显著差异，采用了Santa Cruz Biotech公司的SOCS3抗体，进行了免疫组织化学实验。 更多
信号传导子及转录激活子1 (STAT1)
signal transducer and activator of transcription 1
总数:84
T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response. 2010 至该文献
为了研究富于T细胞/组织细胞的B细胞淋巴瘤的基因转录特征，采用了Santa Cruz Biotechnology的抗STAT1抗体进行免疫组织化学实验。 更多
STAT2
signal transducer and activator of transcription 2
总数:11
A phosphorylation-acetylation switch regulates STAT1 signaling. 2009 至该文献
为了研究磷酸化-乙酰化开关在调控STAT1信号通路中的作用，采用了Santa Cruz Biotechnology公司的STAT2抗体产品，进行了免疫印迹实验。 更多
Tyk2
tyrosine kinase 2
总数:13
Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growth. 2008 至该文献
为研究新型酪氨酸激酶JAK-2抑制剂Z3可以抑制JAK-2介导的病理性细胞生长，采用了Santa Cruz 生物技术公司的抗Tyk2和抗磷酸化TyK2多克隆抗体分别进行免疫共沉淀实验和western免疫印迹实验。 。 更多
UBP43
ubiquitin specific peptidase 18
XAF1
XIAP associated factor 1